WallStreetZenWallStreetZen

NASDAQ: STRM
Streamline Health Solutions Inc Stock

$0.48+0.01 (+2.13%)
Updated Mar 28, 2024
STRM Price
$0.48
Fair Value Price
N/A
Market Cap
$28.24M
52 Week Low
$0.21
52 Week High
$1.90
P/E
-1.41x
P/B
1.43x
P/S
1.02x
PEG
N/A
Dividend Yield
N/A
Revenue
$23.98M
Earnings
-$19.51M
Gross Margin
49.9%
Operating Margin
-77.18%
Profit Margin
-81.4%
Debt to Equity
1.08
Operating Cash Flow
-$5M
Beta
0.58
Next Earnings
Apr 24, 2024
Ex-Dividend
N/A
Next Dividend
N/A

STRM Overview

Streamline Health Solutions, Inc. offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. It provides computer software-based solutions, professional consulting, and auditing and coding services, which capture, aggregate, and translate structured and unstructured data to deliver predictive insights. The company also offers coding and clinical documentation improvement (CDI) solutions, which include an integrated cloud-based software suite, CDI, and abstracting and physician query; and eValuator, a coding analysis platform, as well as software services. In addition, it provides financial management solutions, including accounts receivable management, denials management, claims processing, spend management, and audit management; patient care solutions; Cerner Command Language (CCL) reporting; and custom integration services for CDI/abstracting, training, and audit services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how STRM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

STRM is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
STRM is good value based on its book value relative to its share price (1.43x), compared to the US Health Information Services industry average (3.72x)
P/B vs Industry Valuation
STRM is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more STRM due diligence checks available for Premium users.

Be the first to know about important STRM news, forecast changes, insider trades & much more!

STRM News

Valuation

STRM fair value

Fair Value of STRM stock based on Discounted Cash Flow (DCF)
Price
$0.48
Fair Value
$0.55
Undervalued by
12.28%
STRM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

STRM price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.41x
Industry
79.47x
Market
44.51x

STRM price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.43x
Industry
3.72x
STRM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

STRM's financial health

Profit margin

Revenue
$6.1M
Net Income
-$11.9M
Profit Margin
-194.2%
STRM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
STRM's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$41.1M
Liabilities
$21.4M
Debt to equity
1.08
STRM's short-term liabilities ($12.69M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
STRM's long-term liabilities ($8.67M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
STRM's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
STRM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.2M
Investing
-$536.0k
Financing
$231.0k
STRM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

STRM vs Health Information Service Stocks

TickerMarket Cap1d %P/EP/B
STRM$28.24M+3.00%-1.41x1.43x
HLTH$29.96M+2.72%-0.08x0.12x
ATPC$25.44M-7.30%-16.50x60.14x
ONMD$22.91M+2.01%N/A-1.55x
AKLI$22.77M0.00%-0.38x0.39x

Streamline Health Solutions Stock FAQ

What is Streamline Health Solutions's quote symbol?

(NASDAQ: STRM) Streamline Health Solutions trades on the NASDAQ under the ticker symbol STRM. Streamline Health Solutions stock quotes can also be displayed as NASDAQ: STRM.

If you're new to stock investing, here's how to buy Streamline Health Solutions stock.

What is the 52 week high and low for Streamline Health Solutions (NASDAQ: STRM)?

(NASDAQ: STRM) Streamline Health Solutions's 52-week high was $1.90, and its 52-week low was $0.21. It is currently -74.74% from its 52-week high and 125.35% from its 52-week low.

How much is Streamline Health Solutions stock worth today?

(NASDAQ: STRM) Streamline Health Solutions currently has 58,829,461 outstanding shares. With Streamline Health Solutions stock trading at $0.48 per share, the total value of Streamline Health Solutions stock (market capitalization) is $28.24M.

Streamline Health Solutions stock was originally listed at a price of $4.50 in Dec 31, 1997. If you had invested in Streamline Health Solutions stock at $4.50, your return over the last 26 years would have been -89.33%, for an annualized return of -8.25% (not including any dividends or dividend reinvestments).

How much is Streamline Health Solutions's stock price per share?

(NASDAQ: STRM) Streamline Health Solutions stock price per share is $0.48 today (as of Mar 28, 2024).

What is Streamline Health Solutions's Market Cap?

(NASDAQ: STRM) Streamline Health Solutions's market cap is $28.24M, as of Mar 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Streamline Health Solutions's market cap is calculated by multiplying STRM's current stock price of $0.48 by STRM's total outstanding shares of 58,829,461.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.